Name
Abcentra
Company Description
At Abcentra, we are developing a new class of treatment by pioneering the concept of oxidized low-density lipoprotein (OxLDL) inhibition. OxLDL inhibition targets coronary inflammation in a highly specific manner, thereby maximizing the potential benefit and minimizing treatment-associated risks.
Website
Address
1925 Century Park East, Suite 1700
Los Angeles, 90067
Los Angeles, 90067